Steven M Paul Insider Trades & Stock Holdings

Director · Rapport Therapeutics, Inc. · Latest filing Oct 22, 2026

Steven M Paul, Director at Rapport Therapeutics, Inc. has 1 Form 4 trade on file since Oct 22, 2026. Open-market activity: 1 purchase ($974.28K) and 0 sales ($0), net +$974.28K. Latest filing: acquired 35.71K shares of $RAPP on Oct 22, 2026 at $27.28.

Trades on file

1

Open-market bought

$974.28K

Open-market sold

$0

Net open-market

+$974.28K

Shares held ($RAPP)

77.38K

Latest filing

Oct 22, 2026

Shares held by Steven M Paul

• $RAPP77.38K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Steven M Paul

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 22, 2026	$RAPP	Buy (Open-market buy)	35.71K	$27.28	$974.28K	77.38K	+85.71%				Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Steven M Paul traded

• $RAPP

Frequently asked questions

Has Steven M Paul been buying or selling stock?

Steven M Paul has 1 open-market purchase and 0 open-market sales on file, net +$974.28K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Steven M Paul's latest insider trade?

acquired 35.71K shares of $RAPP on Oct 22, 2026 at $27.28.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.